Abstract
To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.
MeSH terms
-
Africa South of the Sahara / epidemiology
-
Antivenins / therapeutic use*
-
Delivery of Health Care / organization & administration*
-
Health Policy*
-
Rural Health*
-
Snake Bites / epidemiology*
-
Snake Bites / therapy*